BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30737669)

  • 1. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.
    Wong TCL; Ng KKC; Fung JYY; Chan AAC; Cheung TT; Chok KSH; Dai JWC; Lo CM
    Ann Surg Oncol; 2019 May; 26(5):1454-1462. PubMed ID: 30737669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study.
    Azoulay D; Audureau E; Bhangui P; Belghiti J; Boillot O; Andreani P; Castaing D; Cherqui D; Irtan S; Calmus Y; Chazouillères O; Soubrane O; Luciani A; Feray C
    Ann Surg; 2017 Dec; 266(6):1035-1044. PubMed ID: 27617853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
    Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
    J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
    Xiao GQ; Song JL; Shen S; Yang JY; Yan LN
    World J Gastroenterol; 2014 Aug; 20(31):10953-9. PubMed ID: 25152599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation.
    Bhangui P; Vibert E; Majno P; Salloum C; Andreani P; Zocrato J; Ichai P; Saliba F; Adam R; Castaing D; Azoulay D
    Hepatology; 2011 May; 53(5):1570-9. PubMed ID: 21520172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW; Yi NJ; Suh KS
    Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
    Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
    Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living-donor or deceased-donor liver transplantation for hepatic carcinoma: a case-matched comparison.
    Wan P; Zhang JJ; Li QG; Xu N; Zhang M; Chen XS; Han LZ; Xia Q
    World J Gastroenterol; 2014 Apr; 20(15):4393-400. PubMed ID: 24764678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis.
    Liang W; Wu L; Ling X; Schroder PM; Ju W; Wang D; Shang Y; Kong Y; Guo Z; He X
    Liver Transpl; 2012 Oct; 18(10):1226-36. PubMed ID: 22685095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living vs. deceased donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis.
    Grant RC; Sandhu L; Dixon PR; Greig PD; Grant DR; McGilvray ID
    Clin Transplant; 2013; 27(1):140-7. PubMed ID: 23157398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and risk factors of hepatocellular carcinoma treated by liver transplantation: A multi-centre comparison of living donor and deceased donor transplantation.
    Hu Z; Qian Z; Wu J; Zhou J; Zhang M; Zhou L; Zheng S
    Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):315-326. PubMed ID: 26382281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation.
    Li C; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Wei YG
    Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):366-9. PubMed ID: 20688599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living donor liver transplantation for hepatocellular carcinoma.
    Lee SG; Moon DB
    Recent Results Cancer Res; 2013; 190():165-79. PubMed ID: 22941020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
    Lee EC; Kim SH; Shim JR; Park SJ
    Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
    Kulik LM; Fisher RA; Rodrigo DR; Brown RS; Freise CE; Shaked A; Everhart JE; Everson GT; Hong JC; Hayashi PH; Berg CL; Lok AS;
    Am J Transplant; 2012 Nov; 12(11):2997-3007. PubMed ID: 22994906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy.
    Lei J; Yan L; Wang W
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1340-6. PubMed ID: 23652915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation.
    Di Sandro S; Slim AO; Giacomoni A; Lauterio A; Mangoni I; Aseni P; Pirotta V; Aldumour A; Mihaylov P; De Carlis L
    Transplant Proc; 2009 May; 41(4):1283-5. PubMed ID: 19460539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor liver transplantation for hepatocellular carcinoma: the impact of neo-adjuvant treatments on the long term results.
    Di Sandro S; Giacomoni A; Slim A; Lauterio A; Mangoni I; Mihaylov P; Pirotta V; Aseni P; De Carlis L
    Hepatogastroenterology; 2012; 59(114):505-10. PubMed ID: 22353516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
    J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.